Fig. 8. The effect of compounds 1–5, 6, 11, and14 on VEGF-induced migration observed in HUVECs. Data are presented as mean ± SEM of at least three independent experiments. *P <0.05; **P <0.01; ***P <0.001 vs. VEGF-treated control.Published as part of Zhu, Yao, Guan, Yi-Jian, Chen, Qian-Zheng, Yuan, Liao-Heng, Xu, Qian-Qian, Zhou, Mei-Lin, Liu, Hui, Lin, Wei, Zhang, Zong-Duan, Zhou, Zhong-Lou & Dong, Jian-Yong, 2021, Pentacyclic Triterpenes from the resin of Liquidambar formosana have anti-angiogenic properties, pp. 1-9 in Phytochemistry (112676) 184 on page 6, DOI: 10.1016/j.phytochem.2021.112676, http://zenodo.org/record/829201
Fig. 1. Structures of isolated compounds 1–9 from S. concinnula.Published as part of Vo, Thanh-Hoa, ...
Background and Purpose:Drynaria fortunei J. Sm (D. fortunei), known as Gu-Sui-Bu, is used in traditi...
Fig. 6. Effect of compounds 5, 7 and 8 on SMMC7721 cell cycle progression. *P <0.05 vs control.Publi...
Fig. 7. The effect of compounds 1–15 on VEGF-induced mitogenesis observed in HUVECs. Data are presen...
Fig. 9. Inhibitory effects of compound 1 on the phosphorylation of VEGFR2, AKT, and ERK. (A)Western ...
Fig. 1. Structures of compounds 1–15.Published as part of Zhu, Yao, Guan, Yi-Jian, Chen, Qian-Zheng,...
Zhu, Yao, Guan, Yi-Jian, Chen, Qian-Zheng, Yuan, Liao-Heng, Xu, Qian-Qian, Zhou, Mei-Lin, Liu, Hui, ...
Fig. 6. X-ray ORTEP drawing of 3 with ellipsoids drawn at the 30% probability level.Published as par...
Fig. 4. X-ray ORTEP drawing of 1 with ellipsoids drawn at the 30% probability level.Published as par...
Fig. 3. Key NOSEY correlations of compounds 1, 3, 4, and 5.Published as part of Zhu, Yao, Guan, Yi-J...
Fig. 2. Key 1H–1H COSY and HMBC correlations of compounds 1–5.Published as part of Zhu, Yao, Guan, Y...
Fig. 4. The effect of Fr.A, Fr.B, and compounds 1–5, 7 on tube-like structure formation on endotheli...
Fig. 5. Inhibition of FAK/paxillin/MMP signaling pathway treated with 4.Published as part of Vo, Tha...
Vo, Thanh-Hoa, Lin, Yu-Chi, Liaw, Chia-Ching, Pan, Wen-Pin, Cheng, Jing-Jy, Lee, Ching-Kuo, Kuo, Yao...
Fig. 2. Key HMBC and 1H–1H COSY correlations for 1–3 and 5.Published as part of Vo, Thanh-Hoa, Lin, ...
Fig. 1. Structures of isolated compounds 1–9 from S. concinnula.Published as part of Vo, Thanh-Hoa, ...
Background and Purpose:Drynaria fortunei J. Sm (D. fortunei), known as Gu-Sui-Bu, is used in traditi...
Fig. 6. Effect of compounds 5, 7 and 8 on SMMC7721 cell cycle progression. *P <0.05 vs control.Publi...
Fig. 7. The effect of compounds 1–15 on VEGF-induced mitogenesis observed in HUVECs. Data are presen...
Fig. 9. Inhibitory effects of compound 1 on the phosphorylation of VEGFR2, AKT, and ERK. (A)Western ...
Fig. 1. Structures of compounds 1–15.Published as part of Zhu, Yao, Guan, Yi-Jian, Chen, Qian-Zheng,...
Zhu, Yao, Guan, Yi-Jian, Chen, Qian-Zheng, Yuan, Liao-Heng, Xu, Qian-Qian, Zhou, Mei-Lin, Liu, Hui, ...
Fig. 6. X-ray ORTEP drawing of 3 with ellipsoids drawn at the 30% probability level.Published as par...
Fig. 4. X-ray ORTEP drawing of 1 with ellipsoids drawn at the 30% probability level.Published as par...
Fig. 3. Key NOSEY correlations of compounds 1, 3, 4, and 5.Published as part of Zhu, Yao, Guan, Yi-J...
Fig. 2. Key 1H–1H COSY and HMBC correlations of compounds 1–5.Published as part of Zhu, Yao, Guan, Y...
Fig. 4. The effect of Fr.A, Fr.B, and compounds 1–5, 7 on tube-like structure formation on endotheli...
Fig. 5. Inhibition of FAK/paxillin/MMP signaling pathway treated with 4.Published as part of Vo, Tha...
Vo, Thanh-Hoa, Lin, Yu-Chi, Liaw, Chia-Ching, Pan, Wen-Pin, Cheng, Jing-Jy, Lee, Ching-Kuo, Kuo, Yao...
Fig. 2. Key HMBC and 1H–1H COSY correlations for 1–3 and 5.Published as part of Vo, Thanh-Hoa, Lin, ...
Fig. 1. Structures of isolated compounds 1–9 from S. concinnula.Published as part of Vo, Thanh-Hoa, ...
Background and Purpose:Drynaria fortunei J. Sm (D. fortunei), known as Gu-Sui-Bu, is used in traditi...
Fig. 6. Effect of compounds 5, 7 and 8 on SMMC7721 cell cycle progression. *P <0.05 vs control.Publi...